** = Publikationen gelistet in SCI/SSCI/Pubmed
** Fiedler, S; Ambros, IM; Glogova, E; Benesch, M; Urban, C; Mayer, M; Ebetsberger-Dachs, G; Bardi, E; Jones, N; Gamper, A; Meister, B; Crazzolara, R; Amann, G; Dieckmann, K; Horcher, E; Kerbl, R; Brunner-Herglotz, B; Ziegler, A; Ambros, PF; Ladenstein, R
Long-Term Outcome and Role of Biology within Risk-Adapted Treatment Strategies: The Austrian Neuroblastoma Trial A-NB94.
Cancers (Basel). 2021; 13(3):
Doi: 10.3390/cancers13030572
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Krassnig, S; Wohlrab, C; Golob-Schwarzl, N; Raicht, A; Schatz, C; Birkl-Toeglhofer, AM; Skofler, C; Gantenbein, N; Leoni, M; Asslaber, M; Leber, SL; Mahdy-Ali, K; von Campe, G; Mayer, M; Borenich, A; Weis, S; Benesch, M; Haybaeck, J
A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy.
Cancers (Basel). 2021; 13(6):
Doi: 10.3390/cancers13061482
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG